Basit öğe kaydını göster

dc.contributor.authorCelik, Husnu
dc.contributor.authorGungor, Sami
dc.contributor.authorDeniz, Rulin
dc.contributor.authorSahin, Ibrahim
dc.contributor.authorKavak, Burcin
dc.contributor.authorAydin, Suleyman
dc.contributor.authorMinareci, Yağmur
dc.contributor.authorGuzel, Saadet P.
dc.contributor.authorAksoy, Aziz
dc.contributor.authorGurates, Bilgin
dc.contributor.authorBaykus, Yakup
dc.date.accessioned2021-03-05T08:47:36Z
dc.date.available2021-03-05T08:47:36Z
dc.date.issued2012
dc.identifier.citationBaykus Y., Gurates B., Aydin S., Celik H., Kavak B., Aksoy A., Sahin I., Deniz R., Gungor S., Guzel S. P. , et al., "Changes in serum obestatin, preptin and ghrelins in patients with Gestational Diabetes Mellitus", CLINICAL BIOCHEMISTRY, cilt.45, ss.198-202, 2012
dc.identifier.issn0009-9120
dc.identifier.othervv_1032021
dc.identifier.otherav_9ab12752-b78d-46ae-94fa-62aad123acb2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/103993
dc.identifier.urihttps://doi.org/10.1016/j.clinbiochem.2011.08.1131
dc.description.abstractObjectives: The present study aims to establish the levels of acylated ghrelin, desacylated ghrelin, obestatin and preptin, during pregnancy and the postpartum period in pregnant women with Gestational Diabetes Mellitus (GDM) and healthy pregnancy women.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleChanges in serum obestatin, preptin and ghrelins in patients with Gestational Diabetes Mellitus
dc.typeMakale
dc.relation.journalCLINICAL BIOCHEMISTRY
dc.contributor.departmentFırat Üniversitesi , ,
dc.identifier.volume45
dc.identifier.issue3
dc.identifier.startpage198
dc.identifier.endpage202
dc.contributor.firstauthorID103089


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster